Abstract
More women die from breast cancer across the world today than from any other type of malignancy. The clinical course of breast cancer varies tremendously between patients. While some of this variability is explained by traditional clinico-pathological factors (including patient age, tumor stage, histological grade and estrogen receptor status), molecular profiling studies have defined breast cancer subtypes with distinct clinical outcomes. This mini-review considers recent studies which have used genomics technologies in an attempt to identify new biomarkers of prognosis and treatment response. These studies highlight the genetic heterogeneity that exists within breast cancers in space and time.
| Original language | English |
|---|---|
| Article number | 151 |
| Journal | BMC Medicine |
| Volume | 11 |
| Issue number | 1 |
| DOIs | |
| State | Published - 18 Jun 2013 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Breast cancer
- Heterogeneity
- Molecular profiling
- Next-generation sequencing
- Personalized medicine
- Whole-genome sequencing
Fingerprint
Dive into the research topics of 'Genetic heterogeneity in breast cancer: The road to personalized medicine?'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver